PharmAust reappoints Michael Thurn just month after his resignation
PERTH: A Perth clinical-stage biotech firm has reappointed its former chief executive to ... read more
Cromwell makes city health buy in local return
ADELAIDE: Listed property group Cromwell is tapping investors for a new healthcare fund ... read more
Buyback report shows full extent of downfall of Genesis Care
MELBOURNE: GenesisCare’s valuation has slid from a debt-fuelled peak of $5 billion to ... read more
